MedPath

Cervical Spondylotic Myelopathy Surgical Trial

Not Applicable
Active, not recruiting
Conditions
Cervical Spondylosis With Myelopathy
Interventions
Procedure: Dorsal (Back) Decompression with Fusion
Procedure: Ventral (Front) decompression with Fusion
Procedure: Dorsal (back) Laminoplasty
Registration Number
NCT02076113
Lead Sponsor
Lahey Clinic
Brief Summary

The purpose of the study is to determine the optimal surgical approach (ventral vs dorsal) for patients with multi-level cervical spondylotic myelopathy (CSM). There are no established guidelines for the management of patients with CSM, which represents the most common cause of spinal cord injury and dysfunction in the US and in the world.

This study aims to test the hypothesis that ventral surgery is associated with superior Short Form-36 physical component Score (SF-36 PCS) outcome at one year follow-up compared to dorsal approaches and that both ventral and dorsal surgery improve symptoms of spinal cord dysfunction measured using the modified Japanese Orthopedic Association Score (mJOA). A secondary hypothesis is that health resource utilization for ventral surgery, dorsal fusion, and laminoplasty surgery are different. A third hypothesis is that cervical sagittal balance post-operatively is a significant predictor of SF-36 PCS outcome.

Detailed Description

Patients' images will be transmitted electronically (without identifying information) to a group of 15 CSM surgeon investigators for their expert opinion. They will provide their opinion on surgical strategy. Equipoise for randomization will be established using this spinal experts network polling mechanism.

If randomized, the patient will be randomized to one of the two treatment approaches - either Ventral (front) (treatment A) or Dorsal (back) (treatment B) approach. If randomized to treatment A (front surgery), the patient will receive decompression/fusion from the front of the neck. If randomized to treatment B (dorsal/back surgery), then the patient and their surgeon will select which posterior procedure they will receive (either dorsal decompression/fusion or dorsal laminoplasty).

Treatment A: Decompression/fusion from the front of the neck.

Treatment B: Dorsal/posterior neck surgery (one of the two surgical procedures listed below):

Dorsal decompression/fusion or dorsal laminoplasty (no fusion)

Functional outcomes will be determined using well-known quantitative scales (SF-36, Oswestry Neck Disability Index (NDI), mJOA, and EuroQol-5D). These instruments will be administered pre-op, 3 months, 6 months, and at 1 year. Additionally, functional outcomes instruments (SF-36, Oswestry Neck Disability Index, and EuroQol-5D) will be collected annually at years 2,3,4 and 5.

Pre-op imaging will include a cervical MRI and cervical CT as well as cervical flexion/extension films and standing cervical-thoracic-lumbar-sacral x-ray . A cervical MRI will be performed at 3 months. At 1 year (randomized patients only) will undergo cervical flexion/ extension xrays and standing cervical-thoracic-lumbar-sacral x-ray . A cervical CT will be performed only if the Oswestry NDI score is \> 30.

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
269
Inclusion Criteria
  • CSM (≥2 levels of spinal cord compression from C3 to C7)
  • Present with ≥2 of the following symptoms/signs: clumsy hands, gait disturbance, hyperreflexia, up going toes, bladder dysfunction.
Exclusion Criteria
  • C2-C7 kyphosis>5º (measured in standing neutral cervical spine radiograph),
  • Segmental kyphotic deformity (defined by ≥3 osteophytes extending dorsal to a C2-C7 dorsal-caudal line measured on cervical spine CT),
  • Structurally significant ossification of posterior longitudinal ligament (OPLL - measured on cervical spine CT),
  • Previous cervical spine surgery
  • Significant active health-related co-morbidity (Anesthesia Class IV or higher).

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
DorsalDorsal (Back) Decompression with FusionDorsal Decompression with Fusion or Dorsal Laminoplasty
DorsalDorsal (back) LaminoplastyDorsal Decompression with Fusion or Dorsal Laminoplasty
VentralVentral (Front) decompression with FusionVentral Decompression with Fusion
Primary Outcome Measures
NameTimeMethod
Measurement of Change in Short Form 36 (SF 36) Physical Component Score (PCS) From Baseline to 1 Year and 2 Year1 year and 2 year

Standardized measure of patient's functional health and well being as reported by the patient. The SF-36 physical component summary (PCS) scores range from 0 to 100, with higher scores representing better quality of life.

Secondary Outcome Measures
NameTimeMethod
Short Form-36 (SF-36) Physical Component Summary (PCS) ScorePre-operative, 1 year and 2 year

Standardized measure of patient's functional health and well being as reported by the patient. The SF-36 physical component summary (PCS) scores range from 0 to 100, with higher scores representing better quality of life. A typical patient with cervical myelopathy who is being recommended surgery would have a score between 30 and 40.

Oswestry Neck Disability Index (NDI)Pre-operative, 1 year and 2 year

Standard instrument for measuring self-rated disability secondary to neck pain. The NDI ranges from 0 to 100, with lower scores representing less disability. A typical patient with moderate neck pain and disability would have a score between 20 and 40.

EuroQol-5DPre-operative, 1 year and 2 year

Standardized measure of health related quality of life. For the EQ-5D score, 0 indicates death and 1 indicates a perfect health state. EQ-5D scores between 0.6 and 0.7 represent a moderate but significant reduction in overall health-related quality of life.

Modified Japanese Orthopedic Association Score mJOAPre-operative and 1 year

Short instrument for the functional assessment of patients. The scale ranges from 0 to 17, with higher scores representing less dysfunction due to myelopathy. A typical patient with moderate cervical myelopathy has an mJOA score between 12 and 14.

Sagittal Balance Measurements1 year

Sagittal vertical axis was measured at 1 year postoperatively.

Cumulative Health Resource Utilization Over 1 Year by Actual Treatment Groups - Ventral Fusion, Dorsal Fusion, and Dorsal LaminoplastyWithin 1 year of surgery

Patient diary capturing out of pocket health utilization related to cervical surgery. The cumulative health resource utilization over 1-year is reported for the 'as treated' cohorts. Patients reported diagnostic imaging (MRI, x-ray, or CT), along with physical therapy and ongoing (at 1 year) physical therapy, opioid use and ongoing (at 1 year) opioid use, along with appointments with physicians. Data was collected at 1, 3, and 6 months and 1 year after surgery. The data presented is accumulative over the 1 year after surgery.

Number of Participants With Continued Full or Part Time Work Status at Each Follow Up Time Point by Actual Treatment Groups - Ventral Fusion, Dorsal Fusion, and Dorsal LaminoplastyPre-operative, 1, 3 and 6 months and 1 year

Work status was recorded for all patients (working full-time; working part-time; not working, unable to work; not working, but able to work; or retired) at each follow-up through 1 year.

Number of Participants With Unresolved Swallowing Difficulty (Complication) at 3 Months3 months, 1 year

Dysphagia is considered swallowing difficulty. Difficulty swallowing that resolved within 3 months was considered a minor complication, while prolonged (on going after 3 months) dysphagia was considered a major complication.

Number of Participants With Complications by Actual Treatment Groups - Ventral Fusion, Dorsal Fusion, and Dorsal LaminoplastyComplications were assessed at 2 years and categorized to have occurred within 30 days, 1 year or within 2 years.

Major complications included adverse events that were ongoing at 3 months, reoperations within 2 years, and 30-day readmissions. Minor complications were those that resolved within 3 months. All cases of postoperative motor radiculopathy were related to C5 nerve root dysfunction.

Trial Locations

Locations (16)

Lahey Hospital and Medical Center

🇺🇸

Burlington, Massachusetts, United States

Emory

🇺🇸

Atlanta, Georgia, United States

University Health Network-University of Toronto

🇨🇦

Toronto, Ontario, Canada

Cleveland Clinic Foundation

🇺🇸

Cleveland, Ohio, United States

Rutgers-New Jersey Medical School

🇺🇸

Newark, New Jersey, United States

Thomas Jefferson University Hospital

🇺🇸

Philadelphia, Pennsylvania, United States

University of Utah Health Sciences

🇺🇸

Salt Lake City, Utah, United States

MetroHealth

🇺🇸

Cleveland, Ohio, United States

University of Wisconsin

🇺🇸

Madison, Wisconsin, United States

University of Pittsburgh Medical Center

🇺🇸

Pittsburgh, Pennsylvania, United States

University of California- San Francisco

🇺🇸

San Francisco, California, United States

Washington University School of Medicine- St. Louis

🇺🇸

Saint Louis, Missouri, United States

Hospital for Special Surgery

🇺🇸

New York, New York, United States

Columbia

🇺🇸

New York, New York, United States

Medical College of Wisconsin

🇺🇸

Milwaukee, Wisconsin, United States

University of Kansas Medical Center

🇺🇸

Kansas City, Kansas, United States

© Copyright 2025. All Rights Reserved by MedPath